GlassScriptPhysician profile
Krishna Hughes
NPI 1235894122
$3,906.36
in general payments reported to CMS, 2019-2025
20 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $1,000 · 2023: $921 · 2024: $725 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,241 · Education: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.10 |
| Education | $443.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $558.18 | 2021-2025 | Ilumya |
| Janssen Biotech, INC. | $488.01 | 2021-2025 | Tremfya |
| Abbvie INC. | $469.70 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $387.82 | 2021-2025 | |
| Ucb, INC. | $363.99 | 2022-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $359.36 | 2022-2025 | Olumiant, Taltz, Ebglyss |
| Genzyme Corporation | $234.80 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $183.68 | 2021-2025 | Dupixent |
| Pfizer INC. | $178.79 | 2022-2024 | |
| Amgen INC. | $144.48 | 2022-2023 | Otezla |
| Galderma Laboratories, L.P. | $117.65 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.97 | 2023-2024 | Spevigo, Cyltezo |
| E.R. Squibb & Sons, L.L.C. | $90.56 | 2022-2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $81.80 | 2023-2025 | Zoryve |
| Dermavant Sciences, INC. | $33.70 | 2023-2024 | Vtama |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $30.39 | 2025 | Vtama |
| Incyte Corporation | $29.18 | 2022-2023 | Opzelura |
| Sandoz INC. | $19.32 | 2023 | Hyrimoz |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.31 | 2022 | |
| Janssen Scientific Affairs, LLC | $16.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.